Friday, 6 November 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 20, 2026

Vanguard’s 0.05% International Stock ETF Just Outpaced the S&P 500 for the First Time in Five Years

View original at finance.yahoo.com
Vanguard’s 0.05% International Stock ETF Just Outpaced the S&P 500 for the First Time in Five Years Quick Read Vanguard Total International Stock ETF (VXUS) is up 10% year-to-date in 2026, outpacing the Vanguard S&P 500 ETF (VOO) at 8% for the first meaningful YTD lead since 2021, though over a decade VXUS returned 145…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • VEA is up 11% YTD driven by Japanese corporate reform and European industrial revival, while VWO is up 8%.

    60% confidence
  • The US trade deficit narrowed to $60.3 billion in March 2026, after expanding to $72.9 billion in December, suggesting a similar economic environment.

    60% confidence
  • Over a decade, VXUS returned 145% versus VOO's 313.8%, reflecting concentrated US technology exposure's outperformance and the dollar's traditional strength compressing foreign earnings translations.

    60% confidence
  • VXUS is up about 10% year to date in 2026 while VOO has returned roughly 8%, representing the first meaningful YTD lead for VXUS over the S&P 500 since 2021.

    60% confidence
  • An unnamed analyst who called NVIDIA in 2010 has named a new top 10 stocks list for 2026 that does not include Vanguard S&P 500 ETF (VOO).

    60% confidence
  • VXUS tracks the FTSE Global All Cap ex US Index, holds more than 8,000 stocks, charges 0.05% in annual expenses, manages roughly $137 billion, and pays a distribution yield near 2.6%.

    60% confidence
  • The US dollar moved from a 12-month low of $1.198 per euro on January 27, 2026, to roughly $1.16 per euro in mid-May, mechanically compressing the translated value of international earnings for US investors completely separate from underlying foreign business execution.

    60% confidence
  • A weaker US dollar against the euro and improving non-US earnings are driving international stocks higher, though currency strength can reverse gains and emerging markets lack the technology concentration that powered US market returns over the past decade.

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com